Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For QGEN
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -7.31 1.84 1.99
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 27.98 6.49 5.07
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -5.66 16.23 17.20
Cash -15.73 4.03 4.78
Capex 26.69 -0.17 -0.24
Free Cash Flow -4.66 0.43 0.45
Revenue -10.07 2.07 2.30
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -7.31 0.63 0.68
Operating Margin -18.93 0.21 0.26
ROA -13.00 0.01 0.02
ROE -12.62 0.02 0.03
ROIC -26.62 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of QGEN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of QGEN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of QGEN is permitted for members.